ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59.41	23.38	66.84	226.01	78.45
Short-Term Investments	196.55	184.8	139.43	10.97	215.15
Cash & Short-Term Investments	255.96	208.19	206.27	236.98	293.6
Cash Growth	22.95%	0.93%	-12.96%	-19.29%	229.30%
Prepaid Expenses	6.29	4.41	4.18	3.54	3.1
Total Current Assets	262.25	212.6	210.46	240.52	296.7
Property, Plant & Equipment	11.3	12.01	14.24	14.21	1.98
Long-Term Investments	-	26.85	21.95	43.39	-
Other Long-Term Assets	0.59	0.55	0.53	0.52	0.32
Total Assets	274.14	252.01	247.18	298.64	299
Accounts Payable	1.55	0.94	1.32	1.89	0.76
Accrued Expenses	20.12	16.76	11.41	11.34	7.7
Current Portion of Leases	3.18	2.75	2.66	1.93	-
Other Current Liabilities	-	-	-	-	0.55
Total Current Liabilities	24.85	20.46	15.39	15.15	9
Long-Term Leases	6.17	7.46	9.44	10.52	-
Other Long-Term Liabilities	-	-	-	-	0.22
Total Liabilities	31.02	27.92	24.83	25.67	9.22
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-In Capital	805.51	658.75	557.87	518.18	456.2
Retained Earnings	-562.77	-434.93	-334.23	-245.11	-166.39
Comprehensive Income & Other	0.38	0.26	-1.29	-0.1	-0.03
Total Common Equity	243.12	224.09	222.35	272.98	289.78
Shareholders' Equity	243.12	224.09	222.35	272.98	289.78
Total Liabilities & Equity	274.14	252.01	247.18	298.64	299
Total Debt	9.36	10.21	12.1	12.44	-
Net Cash (Debt)	246.6	197.97	194.17	224.54	293.6
Net Cash Growth	24.56%	1.96%	-13.52%	-23.52%	229.30%
Net Cash Per Share	3.54	3.85	4.90	5.92	13.38
Filing Date Shares Outstanding	71.03	67.38	45.09	39.43	36.7
Total Common Shares Outstanding	71.02	54.87	45.09	39.43	36.67
Working Capital	237.4	192.14	195.07	225.37	287.7
Book Value Per Share	3.42	4.08	4.93	6.92	7.90
Tangible Book Value	243.12	224.09	222.35	272.98	289.78
Tangible Book Value Per Share	3.42	4.08	4.93	6.92	7.90
Machinery	8.36	7.39	7.07	5.69	4.76
Leasehold Improvements	2.04	1.97	1.98	1.71	1.71

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q